Status:
NOT_YET_RECRUITING
Prevalence of Blood Pressure Complications During Cesarean Section in Pre-eclamptic Patients (HOPE)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
University Hospital, Lille
Conditions:
Pre-eclampsia
Pre-Eclampsia, Severe
Eligibility:
FEMALE
18+ years
Brief Summary
Preeclampsia (PE) is an obstetric placental vascular pathology with a prevalence of 2 to 5% of pregnant women. It is defined by learned societies by the association of high blood pressure (BP≥140/90mm...
Eligibility Criteria
Inclusion
- Pre-eclamptic patient according to the criteria defined by SFAR 2020.
- Indication of organised or semi-urgent cesarean section (Green or Orange code).
- Adult patient, benefiting from a social security system.
- Oral non-opposition to participation in the study.
Exclusion
- Urgent Cesarean (Red code).
- Patient refusal.
- Patient does not understand French.
- Individual protection measures : guardianship, curatorship.
Key Trial Info
Start Date :
September 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06588023
Start Date
September 5 2024
End Date
September 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Clermont-Ferrand
Clermont-Ferrand, France, 63000